The Patent Finder
FP

Forerunner Pharma Research Co., Ltd.

First filing 2009
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 9 US patents in force on its record. from the record

Of the 9 now held by other companies, 9 name Chugai Seiyaku Kabushiki Kaisha as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2012 to 2032.
US 8,192,740 Pharmaceutical Composition Comprising ANTI-GRP78 Antibody as Active Ingredient Feb 27, 2028
US 9,017,684 Diagnosis and Treatment of Cancer Using Anti-Ereg Antibody Jun 2, 2028
US 8,546,546 Anti-Muc 17 Antibody Jun 21, 2029
US 9,274,119 ANTI-CLDN6 Antibody Mar 23, 2030
US 8,680,243 Diagnosis and Treatment of Cancer Using ANTI-GPR49 Antibody Apr 25, 2030
US 9,139,647 Diagnosis and Treatment of Cancer Using ANTI-TM4SF20 Antibody Apr 29, 2030
US 8,946,385 Chimeric Fc-gamma Receptor and Method for Determination of ADCC Activity by Using the Receptor Sep 4, 2030
US 9,127,071 ANTI-DLL3 Antibody Jan 28, 2031
US 9,079,957 Diagnosis and Treatment of Cancer Using ANTI-TMPRSS11E Antibody May 12, 2032
20162020202420282032
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 89 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2031.
Ends Jan 2031 · High confidence
Also notable
Cited by 24 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Ends Sep 2030 · High confidence
Also notable
Cited by 23 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Ends Apr 2030 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

  • 1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first.
Also on record: 9 patents in force now held by others · 5 patents ended · 9 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited